Citation: Mj. Shelton et al., PREVIOUS INFECTION WITH HELICOBACTER-PYLORI IS THE PRIMARY DETERMINANT OF SPONTANEOUS GASTRIC HYPOACIDITY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED OUTPATIENTS, Clinical infectious diseases, 27(4), 1998, pp. 739-745
Authors:
ADAMS JM
SHELTON MJ
HEWITT RG
GRASELA TH
DEREMER M
MORSE GD
Citation: Jm. Adams et al., RELATIONSHIP BETWEEN DIDANOSINE EXPOSURE AND SURROGATE MARKER RESPONSE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED OUTPATIENTS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 821-826
Authors:
ADAMS JM
SHELTON MJ
HEWITT RG
DEREMER M
DIFRANCESCO R
GRASELA TH
MORSE GD
Citation: Jm. Adams et al., ZALCITABINE POPULATION PHARMACOKINETICS - APPLICATION OF RADIOIMMUNOASSAY, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 409-413
Authors:
SHELTON MJ
ADAMS JM
HEWITT RG
STEINWANDEL C
DEREMER M
COUSINS S
MORSE GD
Citation: Mj. Shelton et al., EFFECTS OF SPONTANEOUS GASTRIC HYPOACIDITY ON THE PHARMACOKINETICS OFZIDOVUDINE AND DIDANOSINE, Pharmacotherapy, 17(3), 1997, pp. 438-444
Authors:
DEREMER M
DAMBROSIO R
BARTOS L
COUSINS S
MORSE GD
Citation: M. Deremer et al., RADIOIMMUNOASSAY OF ZIDOVUDINE - EXTENDED USE AND POTENTIAL APPLICATION, Therapeutic drug monitoring, 19(2), 1997, pp. 195-200
Authors:
MORSE GD
FISCHL MA
SHELTON MJ
COX SR
DRIVER M
DEREMER M
FREIMUTH WW
Citation: Gd. Morse et al., SINGLE-DOSE PHARMACOKINETICS OF DELAVIRDINE MESYLATE AND DIDANOSINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 41(1), 1997, pp. 169-174
Citation: E. Huang et al., COMPARISON OF MEASURED AND ESTIMATED CREATININE CLEARANCE IN PATIENTSWITH ADVANCED HIV DISEASE, Pharmacotherapy, 16(2), 1996, pp. 222-229
Citation: Aj. Chaput et al., IN-VITRO PROTEIN-BINDING CHARACTERISTICS OF DELAVIRDINE AND ITS N-DEALKYLATED METABOLITE, Antiviral research, 32(2), 1996, pp. 81-89
Authors:
MORSE GD
FISCHL MA
SHELTON MJ
BORIN MT
DRIVER MR
DEREMER M
LEE K
WAJSZCZUK CP
Citation: Gd. Morse et al., DIDANOSINE REDUCES ATEVIRDINE ABSORPTION IN SUBJECTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 767-771
Authors:
MORSE GD
ADAMS JM
SHELTON MJ
HEWITT RG
CORDARO JA
Citation: Gd. Morse et al., LACK OF INFLUENCE OF MENSTRUAL-CYCLE ON ZIDOVUDINE (ZDV) PHARMACOKINETICS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 73-73
Authors:
REICHMAN RC
MORSE GD
DEMETER LM
RESNICK L
BASSIAKOS Y
FISCHL M
PARA M
POWDERLY W
LEEDOM J
GREISBERGER C
NEVIN T
WOOD K
MEEHAN PM
GEHEB H
COX S
BATTS D
TIMPONE J
SLACK A
ROYAL M
QUESADA NR
GEISELER PJ
STARK N
NEIDIG J
HILL M
Citation: Rc. Reichman et al., PHASE-I STUDY OF ATEVIRDINE, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, IN COMBINATION WITH ZIDOVUDINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 171(2), 1995, pp. 297-304
Citation: Mm. Foisy et al., PANCREATITIS DURING INTRAVENOUS PENTAMIDINE THERAPY IN AN AIDS PATIENT WITH PRIOR EXPOSURE TO DIDANOSINE, The Annals of pharmacotherapy, 28(9), 1994, pp. 1025-1028
Citation: Mj. Shelton et al., PROLONGED, BUT NOT DIMINISHED, ZIDOVUDINE ABSORPTION INDUCED BY A HIGH-FAT BREAKFAST, Pharmacotherapy, 14(6), 1994, pp. 671-677
Citation: Lm. Rosser et al., IN-VITRO PROTEIN-BINDING CHARACTERISTICS OF ATEVIRDINE AND ITS N-DEALKYLATED METABOLITE, Antiviral research, 25(3-4), 1994, pp. 193-200
Authors:
ODONNELL AM
LETTING DJ
DEREMER MF
MORSE GD
Citation: Am. Odonnell et al., EVIDENCE OF ALKALINE-PHOSPHATASE INTERFERENCE IN A ZIDOVUDINE RADIOIMMUNOASSAY, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2689-2694
Citation: Em. Haase et al., MAPPING OF BACTERICIDAL EPITOPES ON THE P2 PORIN PROTEIN OF NONTYPABLE HAEMOPHILUS-INFLUENZAE, Infection and immunity, 62(9), 1994, pp. 3712-3722
Authors:
CORDARO JA
MORSE GD
BARTOS L
GUGINO LJ
MALISZEWSKI M
COLOMAIO R
SHELTON M
ODONNELL A
HEWITT R
Citation: Ja. Cordaro et al., ZIDOVUDINE PHARMACOKINETICS IN HIV-POSITIVE WOMEN DURING DIFFERENT PHASES OF THE MENSTRUAL-CYCLE, Pharmacotherapy, 13(4), 1993, pp. 369-377
Citation: A. Luzier et Gd. Morse, INTRAVASCULAR DISTRIBUTION OF ZIDOVUDINE - ROLE OF PLASMA-PROTEINS AND WHOLE-BLOOD COMPONENTS, Antiviral research, 21(3), 1993, pp. 267-280
Authors:
KARKI SD
BENTLEY DW
LUZIER A
TAYLOR C
MORSE GD
Citation: Sd. Karki et al., DISPOSITION OF INTRAMUSCULAR CEFONICID IN ELDERLY PATIENTS, Journal of the American Geriatrics Society, 41(8), 1993, pp. 808-810